high risk smoldering multiple myeloma
Showing 1 - 2 of 2
Multiple Myeloma, High Risk Smoldering Multiple Myeloma Trial in United States (Ixazomib (MLN9708), Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- High Risk Smoldering Multiple Myeloma
- Ixazomib (MLN9708)
- Dexamethasone
-
Basking Ridge, New Jersey
- +5 more
Nov 15, 2022
High Risk Smoldering Multiple Myeloma Trial in New York (Ibrutinib)
Terminated
- High Risk Smoldering Multiple Myeloma
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Nov 18, 2020